New England Research & Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.12M Hold
15,950
0.53% 66
2025
Q1
$1.17M Buy
15,950
+9,800
+159% +$720K 0.6% 57
2024
Q4
$403K Hold
6,150
0.21% 114
2024
Q3
$479K Hold
6,150
0.22% 112
2024
Q2
$480K Sell
6,150
-200
-3% -$15.6K 0.23% 127
2024
Q1
$430K Hold
6,350
0.21% 122
2023
Q4
$428K Sell
6,350
-300
-5% -$20.2K 0.23% 117
2023
Q3
$450K Hold
6,650
0.26% 110
2023
Q2
$476K Hold
6,650
0.28% 94
2023
Q1
$462K Sell
6,650
-200
-3% -$13.9K 0.27% 108
2022
Q4
$464K Hold
6,850
0.27% 110
2022
Q3
$376K Hold
6,850
0.24% 117
2022
Q2
$453K Sell
6,850
-4,700
-41% -$311K 0.26% 111
2022
Q1
$766K Sell
11,550
-4,275
-27% -$284K 0.4% 82
2021
Q4
$922K Sell
15,825
-4,100
-21% -$239K 0.45% 72
2021
Q3
$1.2M Buy
19,925
+3,775
+23% +$227K 0.63% 55
2021
Q2
$967K Sell
16,150
-5,200
-24% -$311K 0.5% 72
2021
Q1
$1.06M Sell
21,350
-125
-0.6% -$6.22K 0.58% 63
2020
Q4
$1.07M Buy
21,475
+15,725
+273% +$786K 0.66% 54
2020
Q3
$315K Sell
5,750
-157
-3% -$8.6K 0.23% 106
2020
Q2
$312K Hold
5,907
0.22% 121
2020
Q1
$264K Hold
5,907
0.23% 114
2019
Q4
$295K Hold
5,907
0.2% 132
2019
Q3
$263K Hold
5,907
0.19% 136
2019
Q2
$244K Hold
5,907
0.17% 147
2019
Q1
$239K Hold
5,907
0.16% 148
2018
Q4
$224K Sell
5,907
-100
-2% -$3.79K 0.18% 142
2018
Q3
$238K Hold
6,007
0.15% 141
2018
Q2
$211K Hold
6,007
0.14% 156
2018
Q1
$210K Sell
6,007
-1,400
-19% -$48.9K 0.14% 150
2017
Q4
$257K Sell
7,407
-9,400
-56% -$326K 0.18% 128
2017
Q3
$569K Buy
16,807
+9,657
+135% +$327K 0.42% 88
2017
Q2
$244K Sell
7,150
-9,915
-58% -$338K 0.18% 137
2017
Q1
$531K Sell
17,065
-2,000
-10% -$62.2K 0.41% 81
2016
Q4
$521K Buy
19,065
+12,840
+206% +$351K 0.41% 81
2016
Q3
$205K Sell
6,225
-19,525
-76% -$643K 0.17% 156
2016
Q2
$777K Buy
+25,750
New +$777K 0.67% 44
2015
Q3
Sell
-6,600
Closed -$210K 164
2015
Q2
$210K Hold
6,600
0.17% 164
2015
Q1
$226K Hold
6,600
0.19% 154
2014
Q4
$232K Buy
6,600
+500
+8% +$17.6K 0.2% 160
2014
Q3
$218K Hold
6,100
0.19% 158
2014
Q2
$227K Buy
+6,100
New +$227K 0.2% 143